U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H19N.HNO3
Molecular Weight 324.3737
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Phenindamine Nitrate

SMILES

O[N+]([O-])=O.CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4

InChI

InChIKey=VNPBUNUBQYZEKS-UHFFFAOYSA-N
InChI=1S/C19H19N.HNO3/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14;2-1(3)4/h2-10,19H,11-13H2,1H3;(H,2,3,4)

HIDE SMILES / InChI

Molecular Formula C19H19N
Molecular Weight 261.3609
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula HNO3
Molecular Weight 63.0128
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18907211

Phenindamine (thephorin or 2-methyl-9-phenyl-2,3,4,9-tetrahydro-1-pyridindene) a pyridindene derivative proved to be a potent antihistaminic. Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
THEPHORIN

Approved Use

Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.

Launch Date

-7.1634243E11
PubMed

PubMed

TitleDatePubMed
Treatment of allergic and some other dermatoses with thephorin; a preliminary report.
1947 Aug
Thephorin in the treatment of disseminated neurodermatitis.
1948 Aug
The effects of phenindamine tartrate on sleepiness and psychomotor performance.
1992 Dec
The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor.
1995 Aug 18
Patents

Patents

Sample Use Guides

The maximum amount of phenindamine that you should take in 1 day is 75 mg.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:55:21 UTC 2023
Edited
by admin
on Sat Dec 16 19:55:21 UTC 2023
Record UNII
7EXK7X55BR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Phenindamine Nitrate
Common Name English
1H-Indeno[2,1-c]pyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-, nitrate
Systematic Name English
1H-Indeno[2,1-c]pyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-, nitrate (1:1)
Systematic Name English
2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine,nitricacid
Systematic Name English
Code System Code Type Description
PUBCHEM
71338160
Created by admin on Sat Dec 16 19:55:21 UTC 2023 , Edited by admin on Sat Dec 16 19:55:21 UTC 2023
PRIMARY
CAS
114226-44-7
Created by admin on Sat Dec 16 19:55:21 UTC 2023 , Edited by admin on Sat Dec 16 19:55:21 UTC 2023
PRIMARY
FDA UNII
7EXK7X55BR
Created by admin on Sat Dec 16 19:55:21 UTC 2023 , Edited by admin on Sat Dec 16 19:55:21 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE